Larvol Delta - AVM-Biotechnology-Announces-Full-Enrollment-of-First-Cohort-of-RelapsedRefractory-NonHodgkin39s-Lymphoma-Patients-Dosed-with-AVM0703-at-major-Cancer-Centers-in-USA

dexamethasone sodium phosphate (AVM0703) - AVM Biotechnology

https://www.prnewswire.com/news-releases/avm-biotechnology-announces-full-enrollment-of-first-cohort-of-relapsedrefractory-non-hodgkins-lymphoma-patients-dosed-with-avm0703-at-major-cancer-centers-in-usa-301263637.html

Apr 7, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next